J. Cho et al. / Tetrahedron: Asymmetry xxx (2015) xxx–xxx
5
CDCl3, ppm): 171.6, 142.5, 141.2, 134.6, 127.0, 77.3, 37.4, 33.0,
30.7, 30.6, 30.5, 30.4, 26.7, 23.8, 22.4, 15.2, 0.0; HPLC (R,R)Whelk-
72 h, then quenched with H2O, and extracted with CH2Cl2. The
organic layer was washed with brine, dried over magnesium sul-
fate, and filtered through a Celite pad. The filtrate was concen-
trated under reduced pressure and purified by silica gel
chromatography (hexane/EtOAc = 9:1) to give the product.
O1,
n-hexane/2-propanol = 97:3,
flow
rate = 1.0 mL/min,
UV = 217 nm, retention times 3.72 min (S), 5.72 min (R); HRMS:
[C22H38O2Si]+ 362.2641, found: 362.2640.
4.3.8. (R)-1-(3-(Trimethylsilyl)phenyl)ethyl acetate 5a
4.4.1. (R)-1-Phenylheptan-1-ol 7a
[
a
]
25 = +66.9 (c 0.65, CHCl3) >99% ee {lit.14
[
a
]
20 = +70.8 (c 1.0,
[a] [a]
25 = +31.8 (c 1.1, CHCl3) >99% ee {lit.8c 28 = +35.3 (c 1.04,
D D
D
D
CHCl3) >99% ee}; 1H NMR (300 MHz, CDCl3, ppm): d 7.47–7.42
(m, 2H), 7.35–7.25 (m, 2H), 5.92–5.81 (m, 1H), 2.07 (s, 3H), 1.56–
1.53 (m, 3H), 0.26 (s, 9H); 13C NMR (75 MHz, CDCl3, ppm): 171.4,
142.0, 141.9, 134.0, 132.1, 129.0, 127.7, 73.6, 23.3, 22.5, 0.0;
CHCl3, >99% ee)}; 1H NMR (300 MHz, CDCl3, ppm): d 7.23–7.37
(m, 5H), 4.67–4.63 (m, 1H), 1.83–1.70 (m, 3H), 1.43–1.21 (m,
8H), 0.89–0.83 (m, 3H); 13C NMR (75 MHz, CDCl3, ppm): 144.9,
128.4, 127.4, 125.8, 74.7, 39.1, 31.7, 29.1, 25.8, 22.5, 14.0; HPLC
Chiralcel-OD, n-hexane/2-propanol = 97:3, flow rate = 1.0 mL/min,
UV = 217 nm, retention times 10.9 min (R), 13.1 min (S).
HPLC
(R,R)Whelk-O1,
n-hexane/2-propanol = 97:3,
flow
rate = 1.0 mL/min, UV = 217 nm, retention times 4.78 min (S),
8.41 min (R); TOF-MS (ESI+) calcd for [C13H20O2SiÀOAc]+
177.10995, found: 177.10213.
4.4.2. (R)-1-Phenylnonan-1-ol 7b
[a] [a]
21 = +29.2 (c 0.55, CHCl3) >99% ee {lit.10a 25 = +27.3 (c 1.42,
D D
4.3.9. (R)-1-(3-(Trimethylsilyl)phenyl)propyl acetate 5b
CHCl3, 92% ee)}; 1H NMR (300 MHz, CDCl3, ppm): d 7.34–7.24 (m,
5H), 4.67–4.62 (m, 1H), 1.89–1.68 (m, 3H), 1.44–1.18 (m, 12H),
0.87 (t, J = 6.5 Hz, 3H); 13C NMR (75 MHz, CDCl3, ppm) 145.0,
128.4, 127.5, 125.9, 74.7, 39.1, 31.9, 29.5, 29.3, 25.8, 22.7, 14.1;
[a] [a]
25 = +73.5 (c 1.1, CHCl3) >99% ee {lit.14 20 = +76.8 (c 1.0,
D D
CHCl3) >99% ee}; 1H NMR (300 MHz, CDCl3, ppm): d 7.45–7.42
(m, 2H), 7.33–7.29 (m, 2H), 5.94–5.90 (m, 1H), 2.07 (s, 3H), 1.94–
1.78 (m, 2H), 0.91–0.86 (m, 3H), 0.26 (s, 9H); 13C NMR (75 MHz,
CDCl3, ppm): 171.5, 141.7, 140.8, 133.9, 132.5, 128.8, 128.0, 77.7,
30.5, 22.4, 11.1, 0.0; HPLC (R,R)Whelk-O1, n-hexane/2-propa-
nol = 97:3, flow rate = 1.0 mL/min, UV = 217 nm, retention times
4.22 min (S), 7.60 min (R).
HPLC
Chiralcel-OD,
n-hexane/2-propanol = 97:3,
flow
rate = 1.0 mL/min, UV = 217 nm, retention times 9.10 min (R),
10.4 min (S); HRMS: [C15H24O]+ 220.1827, found: 220.1825.
4.4.3. (R)-1-Phenylundecan-1-ol 7c
[a] [a]
23 = +23.7 (c 0.5, CHCl3) >99% ee {lit.11b 25 = +16.3 (c 2.2,
D D
CHCl3, 88% ee)}; 1H NMR (300 MHz, CDCl3, ppm): d 7.35–7.26 (m,
5H), 4.68–4.65 (m, 1H), 1.82–1.65 (m, 3H), 1.44–1.18 (m, 16H),
0.87 (t, J = 6.5 Hz, 3H); 13C NMR (75 MHz, CDCl3, ppm): 145.0,
128.4, 127.5, 125.9, 74.7, 39.1, 31.9, 29.6, 29.5, 29.3, 25.8, 22.7,
14.1; HPLC Chiralcel-OD, n-hexane/2-propanol = 97:3, flow
rate = 1.0 mL/min, UV = 217 nm, retention times 8.29 min (R),
9.36 min (S); HRMS: [C17H28O]+ 248.2140, found: 248.2140.
4.3.10. (R)-1-(3-(Trimethylsilyl)phenyl)butyl acetate 5c
[a]
25 = +69.0 (c 0.8, CHCl3) >99% ee; 1H NMR (300 MHz, CDCl3,
D
ppm): d 7.35–7.31 (m, 2H), 7.26–7.21 (m, 2H), 5.78–5.68 (m, 1H),
2.06 (s, 3H), 1.98–1.81 (m, 1H), 1.80–1.57 (m, 1H), 1.42–1.15 (m,
2H), 0.94–0.89 (m, 3H), 0.26 (s, 9H); 13C NMR (75 MHz, CDCl3,
ppm): 171.5, 141.8, 141.1, 133.9, 132.5, 128.9, 128.0, 77.1, 39.7,
22.4, 19.9, 14.9, 0.0; HPLC (R,R)Whelk-O1, n-hexane/2-propa-
nol = 97:3, flow rate = 1.0 mL/min, UV = 217 nm, retention times
4.11 min (S), 6.38 min (R); HRMS: [C15H24O2Si]+ 264.1546, found:
264.1543.
4.5. General procedure for halodesilylation of dynamic kinetic
resolution product
4.3.11. (R)-1-(3-(Trimethylsilyl)phenyl)pentyl acetate 5d
To a solution of dynamic kinetic resolution product (0.1 mmol,
>99% ee) in MeOH (0.1 M, 1 mL) were added N-chlorosuccinimide
(1.2 equiv, 16 mg) and KCl (1.2 equiv, 9 mg) or KBr (1.2 equiv,
14 mg). The resulting solution was stirred at 60 °C for 2 h and then
quenched with H2O. The mixture was then extracted with CH2Cl2.
The combined organic phase was dried over magnesium sulfate
and filtered through a Celite pad. The filtrate was concentrated
under reduced pressure and purified by silica gel chromatography
(hexane/EtOAc = 9:1) to give the product.
[a]
25 = +64.8 (c 1.0, CHCl3) 97% ee; 1H NMR (300 MHz, CDCl3,
D
ppm): d 7.45–7.35 (m, 2H), 7.33–7.29 (m, 2H), 5.76–5.68 (m, 1H),
2.06 (s, 3H), 1.98–1.83 (m, 1H), 1.81–1.60 (m, 1H), 1.45-1.10 (m,
4H), 0.92–0.85 (m, 3H), 0.26 (s, 9H); 13C NMR (75 MHz, CDCl3,
ppm) 171.5, 141.8, 141.1, 133.9, 132.5, 128.8, 128.0, 77.4, 37.2,
28.8, 23.5, 22.4, 15.0, 0.0; HPLC (R,R)Whelk-O1, n-hexane/2-propa-
nol = 97:3, flow rate = 1.0 mL/min, UV = 217 nm, retention times
4.29 min (S), 7.62 min (R); HRMS: [C16H26O2Si]+ 278.1702, found:
278.1704.
4.5.1. (R)-1-(4-Chlorophenyl)heptan-1-ol 8a
4.3.12. (R)-1-(3-(Trimethylsilyl)phenyl)heptyl acetate 5e
[a] [a]
25 = +26.1 (c 0.3, CHCl3) >99% ee {lit.11d 25 = +28.2 (c 1.0,
D D
[a]
25 = +32.3 (c 1.0, CHCl3) >99% ee; 1H NMR (300 MHz, CDCl3,
D
CHCl3) 96% ee}; 1H NMR (300 MHz, CDCl3, ppm): d 7.32–7.25 (m,
4H), 4.72–4.65 (m, 1H), 1.90–1.61 (m, 3H), 1.50–1.21 (m, 8H),
0.95–0.81 (m, 3H); 13C NMR (75 MHz, CDCl3, ppm): 143.4, 133.0,
128.4, 127.3, 73.9, 39.1, 31.7, 29.1, 25.6, 22.6, 14.0; HPLC
ppm): d 7.44–7.40 (m, 2H), 7.33–7.25 (m, 2H), 5.76–5.71 (m, 1H),
2.06 (s, 3H), 1.91–1.86 (m, 1H), 1.81–1.70 (m, 1H), 1.45–1.05 (m,
8H), 0.92–0.84 (m, 3H), 0.26 (s, 9H); 13C NMR (75 MHz, CDCl3,
ppm): 171.5, 141.7, 141.1, 133.9, 132.5, 128.8, 128.0, 77.4, 37.5,
32.7, 30.1, 26.6, 23.6, 22.4, 15.1, 0.0; HPLC (R,R)Whelk-O1, n-hex-
ane/2-propanol = 97:3, flow rate = 1.0 mL/min, UV = 217 nm,
retention times 3.86 min (S), 7.29 min (R); HRMS: [C18H30O2Si]+
306.2015, found: 306.2018.
(R,R)Whelk-O1,
n-hexane/2-propanol = 97:3,
flow
rate = 1.0 mL/min, UV = 217 nm, retention times 4.21 min (S),
9.93 min (R), acetate-form.
4.5.2. (R)-1-(4-Chlorophenyl)nonan-1-ol 8b
4.4. General procedure for the desilylation of dynamic kinetic
resolution products
[a]
22 = +23.9 (c 0.6, CHCl3) >99% ee; 1H NMR (300 MHz, CDCl3,
D
ppm): d 7.33–7.25 (m, 4H), 4.66–4.61 (m, 1H), 1.91–1.61 (m, 3H),
1.45–1.19 (m, 12H), 0.87 (t, J = 6.5 Hz, 3H); 13C NMR (75 MHz,
CDCl3, ppm): 143.4, 133.1, 128.5, 127.3, 74.0, 39.2, 31.8, 29.5,
29.2, 25.7, 22.6, 14.1; HPLC (R,R)Whelk-O1, n-hexane/2-propa-
nol = 97:3, flow rate = 1.0 mL/min, UV = 217 nm, retention times
To
(0.1 mmol, >99% ee) in DMF (1 mL) was added 1.0 M TBAF in THF
(6.0 equiv, 600 L). The resulting solution was stirred at 60 °C for
a solution of the dynamic kinetic resolution product
l